9-CHLORO-11.BETA.-HYDROXY-21-((METHANESULFONYL)OXY)-16.ALPHA.-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-17-YL FURAN-2-CARBOXYLATE
UNII ADJ6C33CEK
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-chloro-11.beta.-hydroxy-21-((methanesulfonyl)oxy)-16.alpha.-methyl-3,20-dioxopregna-1,4-dien-17-yl Furan-2-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ADJ6C33CEK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1370190-08-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H33ClO9S AVTGVLGPYCPSRO-OKCRLJKSSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-chloro-11.beta.-hydroxy-21-((methanesulfonyl)oxy)-16.alpha.-methyl-3,20-dioxopregna-1,4-dien-17-yl Furan-2-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.